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should be considered ﬁrst author.IntroductionRift Valley fever virus (RVFv) is an arthropod-borne Phlebovirus
in the family Bunyaviridae, with widespread epidemiology
throughout sub-Saharan African regions ﬁrst reported in the
early 1900s by a veterinary surgeon in Kenya [1]. The virus is
maintained and transmitted by mosquitoes, mainly Aedes and
Culex species [1,2]. Though the virus has been shown to be
maintained in mosquito populations through vertical and hori-
zontal transmission [3], there has also been evidence of itsNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artimaintenance in mammalian reservoirs, and there remains the
possibility that there are other uncharacterized wildlife reser-
voirs which allow transmission at the wildlife/domesticated
livestock interface via mosquito [4].
The epidemiologic range of the virus has been increasing,
with reported outbreaks in West Africa, Saudi Arabia,
North Africa and southern Africa [5–9]. There is evidence that
RVFv is capable of transmission through a varied repertoire of
diverse anthropophilic mosquito species, primarily Aedes and
Culex species [10]. Indications of increasing diversity of vector
competence may lead to rapid expansions in the future, which
may pose a risk to countries geographically farther from
traditional areas considered endemic [11].
Increasing circulation of RVFv in competent mosquito pop-
ulations is a common observation in endemic areas after
increased rainfall; it is usually followed by increased trans-
mission to domesticated animals, where it is capable of causing
severe animal health problems such as abortion [11–13]. ThisNew Microbe and New Infect 2016; 9: 1–7
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communities, particularly in arid areas that rely on geographi-
cally limited agriculture. An increased prevalence in human
disease is also observed, particularly amongst agricultural
workers, who are at a higher risk of exposure via mosquito
bite, and abattoir workers or butchers, who are at risk of
exposure via contaminated blood when preparing meat from
infected animals [13]. Exposure via the bodily ﬂuids of infected
animals and also via aerosolization of the virus during butch-
ering has been previously suggested as a major route of
exposure for high-risk groups [14] and may put an individual at
higher risk of developing more severe clinical symptoms, such
as haemorrhagic manifestations due to exposure to higher viral
titres.
Rift Valley fever outbreaks are regularly reported in East
Africa and have also been reported in Mauritania [8]. One
recent study identiﬁed Tunisia as a high-risk country; the au-
thors inferred that environmental conditions and the presence
of the vector meant that an epizootic occurrence was possible
if the virus was present—a constant and considerable risk
throughout the year, with a particularly high probability in July,
after the wettest months [15]. Previous studies looking for
serologic evidence of exposure to Rift Valley fever in
2006–2007 found no positivity in the studied population [16].
Indeed, as a result of anthropogenic inﬂuences such as irrigation
and well drilling, surface water levels in several arid regions
have increased over the years, allowing the emergence of
vector-borne diseases due to the wider distribution of
competent mosquitos throughout the country [17], thus
increasing potential risk since previous studies were performed
in both human and animal populations. On the basis of math-
ematical modelling, Tunisia is considered at risk for RVFv [15].
In this study, we performed a seroepidemiologic survey to
demonstrate circulation of RVFv in Tunisia.Materials and MethodsStudy sites
Tunisia covers a wide climatic range, from a Mediterranean
climate, with its rainy winter, in the north to a Saharan climate
in the south (Fig. 1). The northern part of the country is
separated from the south by the Tunisian Ridge, a range of hills
running northeast to southwest for approximately 220 km,
marking the climatic boundary between the Mediterranean Sea
to the north and the dry steppes of central Tunisia. Between
the northern slopes of the Tunisian Ridge and the chains of hills
bounding it on the south are extensive plateaus, called the High
Tell. The Sahara is separated from the central steppe land by a
series of salted areas called chotts.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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Samples were collected from patients seeking care at hospitals
who had reported unexplained acute fever (n = 181). Samples
were also actively taken from abattoir workers (n = 38) in or-
der to survey evidence of previous exposure amongst groups
designated to be at high risk of infection. Most participants
originated from the governorates of Sousse, Sfax and Mahdia
(Fig. 1), and samples were collected during the summer of 2014.
All participants were asked for history of tick and/or mosquito
bites. Samples were collected by Vacutainer, and plasma was
separated, frozen at −20°C and transported to Public Health
England Porton Down, UK, for analysis. The study was con-
ducted after receipt of ethical approval from the ethical com-
mittee (HHS-IRB 00008931; Farhat Hached University Hospital,
protocol reference date 8 April 2013).
RNA extraction and PCR
Nucleic acid extraction was performed using a QiaAmp Viral
RNA Mini kit (Qiagen) according to the manufacturer’s in-
structions. Puriﬁed RNA was stored at −20°C until required.
Ampliﬁcation was performed using a previously published assay
[18] as follows: forward: 50-AAAGGAACAATGGACTCT
GGTCA-30; reverse: 50-CACTTCTTACTACCATGTCCTC-
CAAT-30, probe 50-6FAM AAAGCTTTGATATCTCTCAGTG
CCCCAA BHQ1-30. Reverse transcriptase (RT)-PCR assays
were conducted in one step using the Superscript III quantita-
tive real-time PCR (qRT-PCR) kit (Life Technologies) according
to the manufacturer’s instructions with cycling conditions of
50°C for 10 minutes and 95°C for 2 minutes, followed by 40
cycles of 95°C for 10 seconds and 60°C for 40 seconds, fol-
lowed by holding at 40°C for 2 minutes. Data acquisition was
performed using the ABI 7500 Real-Time PCR machine
(Applied Biosystems) with 45 analysed cycles with a threshold
of 0.05 and data analysed using the ABI 7500 on-board
software.
Indirect immunoﬂuorescence assay
Sera were tested for the presence of antibodies reactive to RVFv
using commercially available indirect immunoﬂuorescence
testing kits (Euroimmun). All serum samples were tested for the
presence of RVFv by qRT-PCR before serologic testing under
Containment Level 2 conditions. In brief, sera samples were
diluted 1/100 and incubated on irradiated/ﬁxed RVFv infected
and noninfected Vero cells for 60 minutes at room temperature
before washing ﬁve times for 5minutes in sample buffer including
0.1% Tween 20. Antibodies binding to the infected cells were
detected and measured through a secondary antibody labelled
with ﬂuorescein isothiocyanate; 1/100 was set as the minimum
cutoff. For immunoglobulin (Ig) Mmeasurement, the process was
modiﬁed by initial dilution of sera in EUROSORB IgG removalEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 1–7
nses/by-nc-nd/4.0/)
FIG. 1. Bioclimatic map of Tunisia showing sampling sites, with governorates from which samples were derived for this study highlighted.
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before. Slides were mounted in mounting media and viewed
under a ﬂuorescent microscope at excitation/emission peaks of
495/517 nm, respectively. Positive and negative controls pro-
vided with the commercial kit were tested to provide a bench-
mark to which samples were compared.ResultsSamples collected from patients with acute fever were initially
tested according to local protocols for serologic reactivity to
Brucella, Rickettsia andWest Nile virus and the presence of these
agents through blood and urine cultures. All samples in this study
were shown to be negative during this testing phase and were
sent to Public Health England Porton Down to be analysed for
Rift Valley fever by both molecular and serologic testing.
In total 219 samples were tested by qRT-PCR and indirect
immunoﬂuorescence to ascertain the level of exposure in the
study population. Commercial immunoﬂuorescence controls
were tested to provide a benchmark to which samples could be
compared. The commercial immunoﬂuorescence assay test kit
utilized in this study is European Community (CE) marked as a
diagnostic kit and has been validated in house for diagnostic useFIG. 2. Representation of percentage of immunoglobulin (Ig) G–positive an
presentation to hospital, and nonfebrile worker cohort collected actively fro
amongst nonfebrile patients compared to IgM in febrile patients, 7.8% IgG an
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of RVFv was not detected by qRT-PCR in either cohort;
however, 7.8% of the tested nonfebrile cohort showed IgG
serologic reactivity (n = 3) to RVFv at the screening dilution, a
reaction shown to be repeatable on retesting (Fig. 2).
Furthermore, 8.3% of febrile patients were found to have
circulating IgM reactive to RVFv (n = 15). Samples which tested
positive by IgG and IgM were titrated to 1/10 000 dilutions in
phosphate-buffered saline to evaluate the abundance of reactive
antibody.
The 18 serologically reactive samples were derived from
patients and participants in the governorates of Sousse, Mahdia
and Sfax, areas highlighted in the bioclimatic map comprising
Fig. 1. Fifteen samples drawn from febrile patients showed only
IgM reactivity. In contrast, three seropositive samples drawn
from afebrile farmers and abattoir workers showed only IgG
reactivity, with IgM absent (Table 1). Clinical details were taken
for all samples collected during this study, in line with normal
clinical practice in Tunisia, including travel history.
Two samples were titrated beyond the screening dilution
(Fig. 3). Sample 48 showed some ﬂuorescence at 1/1000 dilu-
tion; however, on retest, it failed to titrate beyond 1/100.
Sample 42 titrated beyond this, to 1/10 000, making this the
strongest IgM reaction detected in this study.d IgM-positive samples detected in febrile patient cohort collected at
m volunteers in rural areas. Data show similar levels of IgG positivity
d 8.3% IgM.
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TABLE 1. Positive samples, cohort and associated results
Sample ID Type IgG IgM Conﬁrmation PCR Outcome Origin
TUN/008 Farmer Sera 1:100 Negative IgG Positive Negative RVF IgG Positive Sfax
TUN/026 Farmer Sera 1:100 Negative IgG Positive Negative RVF IgG Positive Sousse
TUN/028 Farmer Sera 1:100 Negative IgG Positive Negative RVF IgG Positive Sousse
TUN/042 Febrile Patient Negative 1:10000 IgM Positive Negative RVF IgM Positive Sousse
TUN/048 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/053 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sfax
TUN/078 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sfax
TUN/083 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/086 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/089 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/094 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sfax
TUN/102 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Mahdia
TUN/107 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/120 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/123 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/129 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/135 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
TUN/188 Febrile Patient Negative 1:100 IgM Positive Negative RVF IgM Positive Sousse
NMNI Bosworth et al. Rift Valley fever seroprevalence in Tunisia 5DiscussionOur results strongly suggest the presence of active RVFv cir-
culation in Tunisia, conﬁrming our expectation from a recent
appraisal of North Africa for the relative risk of harbouring
circulating RVFv that was recently undertaken [15]. This ﬁnding
is not unexpected, with RVFv also being found in northwesternFIG. 3. Immunoﬂuorescence showing level of ﬂuorescence across several tit
Images of positive and negative controls tested are also shown.
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This is an open access artiAfrica [8,11]. Tunisia is notable for its close proximity to Eu-
ropean Mediterranean countries and the migratory patterns of
birds through the country leading northwards into Europe [11].
There is also evidence of RVFv exposure in bird populations
[19], which are a potential zoonotic risk for vector-borne dis-
ease. For example, birds infested with Hyalomma marginatum,
the principal vector of Crimean-Congo haemorrhagic fever
virus, have been detected as far north as the United Kingdomrations up to dilution 1/10 000 for sample 42 and 1/100 for sample 48.
ehalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 1–7
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pology affect bird migratory routes and vector population size;
both factors result in a high risk of an increase in prevalence of
zoonotic disease [16]. The potential for cross-border trans-
mission through the exchange of economically important animal
species from neighbouring countries may also result in the
importation of zoonotic pathogens at the wildlife–
domesticated livestock interface. Circulation of West Nile virus
in the region is recognized, and investigations have suggested an
increasing prevalence which may be attributable to anthropo-
genic environmental changes [21]. These events illustrate the
need for improved and comprehensive surveillance in areas
where environmental change is recognized to track relative risk
to human and animal health to arthropod-borne diseases such
as RVFv and West Nile virus.
Rift Valley fever, while primarily being transmissible through
the bite of the mosquito vector species, may also be transmitted
through direct contact with blood. There are several anecdotal
reports of veterinary workers engaged in animal necropsies being
exposed to high levels of RVFv during the course of their duties
[22], and surveillance activities have detected prevalence of
reactive antibody and the virus itself in abattoir and slaughter-
house workers [7,14]. Critical to the control measures imposed
during the outbreak in Saudi Arabia in 2000 was the education of
agricultural workers to avoid close contact sick animals and
consumption of diseased meat in order to reduce risk of spread
through direct contact [9]. This riskmay be substantially increased
during certain religious festivals in Tunisia, where the slaughter of
domestic ruminants by individual families disseminates the risk to
amuchwider population. It is notable that in our study no abattoir
or agricultural workers sampled tested positive for IgM, which is
indicative of recent exposure; instead, they only showed signs of
previous historical exposure. However, this may be an artefact of
our results resulting from the small numbers of samples collected
from these populations.
Other countries perceived as being at high risk of RVFv
outbreaks are neighbouring Algeria and Libya [15]. Travel and
trade across the border are common and risk disease impor-
tation. The strong IgM response detected in the course of this
study is indicative of a recent and strong reaction to exposure
to RVFv or a serologically related virus. It is notable that there
was a lack of IgG response seen in any sample from febrile
patients, suggesting collection soon after exposure before
detectable IgG appearing or nonspeciﬁc reactivity with a closely
related Phlebovirus. Additionally, the lack of a detectable virus
genome complicates conﬁrmatory testing, something which
may be attributed to sampling after the viraemic stage of disease
has occurred [23]. Detailed medical records were collected for
all patients and high-risk participants in this study. Of the 18
seroreactive cases, records indicated that none had travelledNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceabroad in the 2 months preceding sampling. Additionally there
was no identiﬁable link between seropositive abattoir workers
and the importation of livestock from abroad for slaughter, as
the peak of importation occurred after the sampling period.
Even so, the possibility remains of a case introduced through
travel or movement of livestock in a country with optimal
conditions for an outbreak.
This study provides evidence to support more detailed and
thorough surveillance activities for RVFv in order to conclu-
sively demonstrate whether these cases are autochthonous
ﬁndings and to survey its prevalence in the region’s indigenous
mosquito populations.ConclusionBecause of the potential for RVFv to create a devastating
agricultural burden, its control becomes critically important
when it is discovered to be circulating in a region. A campaign
of active surveillance, prevention strategies, increased research
and vaccination of livestock all play a role in the control of RVFv
and serve not only to reduce the potential economic burden
but also, by interrupting the virus transmission amongst live-
stock, to interrupt transmission across the human– livestock
interface, thus signiﬁcantly reducing the risk to public health.
Active collaboration between public health and animal health
institutions of Tunisia is critical, as is increasing cohesive plan-
ning with the institutes of neighbouring countries. Though our
study is limited in scope, we hope that it provides a foundation
for further surveillance and investigation of RVFv in Tunisia.AcknowledgementsSupported in part by a grant from the US Civilian Research and
Development Foundation (CRDF) (16953) and with funding
from the UK Biological Engagement Programme (UKBEP). The
authors thank N. A. Sammour and D. Elliott, project managers,
CRDF and UKBEP, respectively, for enabling this collaboration
and providing funding for this work. The views expressed are
those of the authors and not necessarily those of the National
Health Service, the National Institute for Health Research, the
Department of Health, Public Health England or their partner
institutions in Tunisia.Conﬂict of InterestNone declared.European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 1–7
nses/by-nc-nd/4.0/)
NMNI Bosworth et al. Rift Valley fever seroprevalence in Tunisia 7References[1] Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley
fever. An undescribed virus disease of sheep cattle and man from East
Africa. J Pathol 1931;34:545–79.
[2] Dar O, McIntyre S, Hogarth S, Heymann D. Rift Valley fever and a new
paradigm of research and development for zoonotic disease control.
Emerg Infect Dis 2013;19:189–93.
[3] Chevalier V, de la Rocque S, Baldet T, Vial L, Roger F. Epidemiological
processes involved in the emergence of vector-borne diseases: West
Nile fever, Rift Valley fever, Japanese encephalitis and Crimean-Congo
haemorrhagic fever. Rev Sci Tech 2004;23:535–55.
[4] Olive MM, Goodman SM, Reynes JM. The role of wild mammals in the
maintenance of Rift Valley fever virus. J Wildl Dis 2012;48:241–66.
[5] Arthur RR, el-Sharkawy MS, Cope SE, Botros BA, Oun S, Morrill JC,
et al. Recurrence of Rift Valley fever in Egypt. Lancet 1993;342(8880):
1149–50.
[6] Bukbuk DN, Fukushi S, Tani H, Yoshikawa T, Taniguchi S, Iha K, et al.
Development and validation of serological assays for viral hemorrhagic
fevers and determination of the prevalence of Rift Valley fever in Borno
State, Nigeria. Trans R Soc Trop Med Hyg 2014;108(12):768–73.
[7] Durand JP, Bouloy M, Richecoeur L, Peyreﬁtte CN, Tolou H. Rift
Valley fever virus infection among French troops in Chad. Emerg Infect
Dis 2003;9:751–2.
[8] Faye O, Ba H, Ba Y, Freire CC, Faye O, Ndiaye O, et al. Reemergence
of Rift Valley fever, Mauritania, 2010. Emerg Infect Dis 2014;20(2):
300–3.
[9] Hassan OA, Ahlm C, Evander M. A need for one health approach—
lessons learned from outbreaks of Rift Valley fever in Saudi Arabia and
Sudan. Infect Ecol Epidemiol 2014;4.
[10] Turell MJ, Wilson WC, Bennett KE. Potential for North American
mosquitoes (Diptera: Culicidae) to transmit Rift Valley fever virus. J Med
Entomol 2010;47:884–9.
[11] Chevalier V. Relevance of Rift Valley fever to public health in the
European Union. Clin Microbiol Infect 2013;19:705–8.
[12] ShiehWJ, Paddock CD, Lederman E, et al. Pathologic studies on suspect
animal and human cases of Rift Valley fever from an outbreak in Eastern
Africa, 2006–2007. Am J Trop Med Hyg 2010;83(2 suppl.):38–42.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on b
This is an open access arti[13] Coetzer JA. The pathology of Rift Valley fever. II. Lesions occurring in
ﬁeld cases in adult cattle, calves and aborted foetuses. Onderstepoort J
Vet Res 1982;49:11–7.
[14] Abu-Elyazeed R, el-Sharkawy S, Olson J, Botros B, Soliman A, Salib A,
et al. Prevalence of anti-Rift-Valley-fever IgM antibody in abattoir
workers in the Nile delta during the 1993 outbreak in Egypt. Bull
World Health Organ 1996;74(2):155–8.
[15] Arsevska E, Hellal J, Mejri S, Hammami S, Marianneau P, Calavas D,
et al. Identifying areas suitable for the occurrence of Rift Valley fever in
North Africa: implications for surveillance. Transbound Emerg Dis
2015 Feb 6. In press.
[16] Ayari-Fakhfakh E, Ghram A, Bouattour A, Larbi I, Gribâa-Dridi L,
Kwiatek O, et al. First serological investigation of peste-des-petits-
ruminants and Rift Valley fever in Tunisia. Vet J 2011;187(3):402–4.
[17] Barhoumi W, Qualls WA, Archer RS, Fuller DO, Chelbi I, Cherni S,
et al. Irrigation in the arid regions of Tunisia impacts the abundance and
apparent density of sand ﬂy vectors of Leishmania infantum. Acta Trop
2015;141(pt A):73–8.
[18] Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, et al.
Rapid detection and quantiﬁcation of RNA of Ebola and Marburg vi-
ruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley
fever virus, dengue virus, and yellow fever virus by real-time reverse
transcription–PCR. J Clin Microbiol 2002;40(7):2323–30.
[19] Davies FG, Addy PA. Rift Valley fever. A survey for antibody to the
virus in bird species commonly found in situations considered to be
enzootic. Trans R Soc Trop Med Hyg 1979;73:584–5.
[20] Jameson LJ, Morgan PJ, Medlock JM, Watola G, Vaux AG. Importation
of Hyalomma marginatum, vector of Crimean-Congo haemorrhagic
fever virus, into the United Kingdom by migratory birds. Ticks Tick
Borne Dis 2012;3:95–9.
[21] Feki I, Marrakchi C, Ben Hmida M, Belahsen F, Ben Jemaa M, Maaloul I,
et al. Epidemic West Nile virus encephalitis in Tunisia. Neuro-
epidemiology 2005;24(1–2):1–7.
[22] Brett NA, Juno T, Jacqueline W, Ayanda C, Dadja E, Charlene J, et al.
Epidemiologic investigations into outbreaks of Rift Valley fever in
humans, South Africa, 2008–2011. Emerg Infect Dis J 2013;19:1918.
[23] Mansﬁeld KL, Banyard AC, McElhinney L, Johnson N, Horton DL,
Hernández-Triana LM, et al. Rift Valley fever virus: a review of diag-
nosis and vaccination, and implications for emergence in Europe.
Vaccine 2015;33(42):5520–31.ehalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 1–7
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
